Kilitch Drugs (India) Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 235.71 million compared to INR 180.72 million a year ago. Revenue was INR 237.39 million compared to INR 184.94 million a year ago. Net income was INR 21.57 million compared to INR 20.82 million a year ago. Basic earnings per share from continuing operations was INR 1.39 compared to INR 1.34 a year ago. Diluted earnings per share from continuing operations was INR 1.39 compared to INR 1.34 a year ago. For the six months, sales was INR 431.95 million compared to INR 282.64 million a year ago. Revenue was INR 444.17 million compared to INR 290.55 million a year ago. Net income was INR 33.44 million compared to INR 7.48 million a year ago. Basic earnings per share from continuing operations was INR 2.15 compared to INR 0.48 a year ago. Diluted earnings per share from continuing operations was INR 2.15 compared to INR 0.48 a year ago.